C. Griffiths (London, United Kingdom), A. Ostrem (Oslo, Norway)
Accuracy of electronic monitoring device Piko-1
S. Salgado, J. Teixeira, C. Silva, N. Moreira, R. Barros, M. Rocha, P. Calaça, L. Raposo, O. Santos, C. Bárbara (Lisboa, Portugal)
|  |
Influence of intercurrent respiratory tract infections on inhaled human insulin (Exubera®) therapy: a retrospective pooled analysis of controlled phase 2/3 trials
P. Camus, R. J. Riese, J. G. Teeter (Dijon, France; Groton, United States Of America)
| |
Respiratory muscle dysfunction in diabetic obese patients
Y. Turgut, Z. A. Tasdemir, T. Demir, O. Tiryakioglu, G. Can (Istanbul, Turkey)
| |
Assessment of the function of a telemedicine center for chest diseases
P. Ziotopoulos, V. Chandrinos, G. Delaportas, M. Gamvroudi, P. Kalomitsinis, I. Markou, E. Vletsi, M. Zissi (Athens, Greece)
| |
Evaluation of the effects of the trinity system of asthmatic patient education and management
S. Mu, Q. He, B. Yu, Y. Cui, Y. Wang (Beijing, China)
| |
Smoking habits in an asthmatic student population
S. P. Stojanovic Ristic, D. Ilic, M. Mitic Milikic, M. Vukcevic (Belgrade, Serbia And Montenegro)
| |
Calculation of "area under curve" from flow-volume curve in idiopatic pulmonary fibrosis and relationship with other parameters
E. S. Ucan, B. Ozturk, A. Ozmen, A. Hayretdag, S. Ozalevli, O. N. Ucan, A. Ozden (Izmir, Istanbul, Turkey)
| |
Budesonide/formoterol is more cost-effective than salmeterol/fluticasone in severe COPD: a Markov model simulation
S. Borg, A. Ericsson (Lund, Sweden)
| |
Collaboration with non-profit organization, EPAREC (Expert Patient in Respiratory Care) in disseminating asthma management plan
M. Haida, K. Tanaka, H. Tomioka (Tokyo, Yokohama, Japan)
| |
Peak expiratory flow use for screening airflow obstruction and monitoring the bronchodilator effect in COPD patients in primary care settings
V. Tsagaraki, S. Markantonis, A. Amfilochiou (Athens, Greece)
| |
A qualitative study of sleep experiences in subjects with moderate to severe COPD
B. S. Shackell, R. C. M. Jones, J. Campbell, G. Harding, S. Pearse (Plymouth, Exeter, United Kingdom)
| |
Factors influencing cost of asthma drugs in primary care
M. Heibert Arnlind, M. Nokela, C. Rehnberg, E. Wikström Jonsson (Stockholm, Sweden)
| |
Impact of blockers of AT1 receptors to angiotensin II on endothelium vasoregulating function in COPD patients
A. A. Lysenko, V. V. Rodionova (Dnipropetrovsk, Ukraine)
| |
COPD and asthma patients are satisfied with handling and inhalation characteristics of Soft Mist InhalerÔ (Berodual® Respimat®)
F. Freytag, W. Golisch, K. Wolf (Neu-Isenburg, Ingelheim, Germany)
| |
Implementation of asthma guidelines by setting up easy asthma clinic
W. Boonsawat, U. Zaeoui, S. Lerdsinudom, C. Samosorn (Khon Kaen, Thailand)
| |
The effect of short-term training of family physicians as a step of successful PAL implementation
N. N. Brimkulov, T. C. Chubakov, L. Niemi, A. Z. Kalieva, D. V. Vinnikov (Bishkek, Kyrgyzstan)
| |
PAL implementation in Kyrgyzstan via short-term training of family physicians
N. E. Davletalieva, R. A. Cholurova, A. S. Sultanova, L. Niemi (Bishkek, Kyrgyzstan)
| |
COPD patients´ perspectives at the time of diagnosis: a qualitative study
M. Arne, M. Emtner, S. Janson, B. Wilde Larsson (Uppsala, Karlstad, Sweden)
| |
Is there a need for ongoing support for the interpretation of spirometry results by general practitioners?
P. J. P. Poels, T. R. J. Schermer, R. P. Akkermans, M. van den Bogart-Jansen, B. J. A. M. Bottema, C. van Weel (Nijmegen, Netherlands)
| |
Spirometric reference values for Croatian Adriatic elderly
M. B. Pavlovic (Zagreb, Croatia)
| |
Talc pleurodesis: lung dispersion of talc using talc of different size particles
E. H. Genofre, F. S. Vargas, M. M. P. Acencio, L. Antonangelo, L. R. Teixeira, V. R. Figueiredo, E. Marchi (Sao Paulo, Brazil)
| |
Spirometry fundamentals: a computer-based guide to lung function testing
H. K. Powell, H. J. Lynch, J. W. Stout (Seattle, United States Of America)
| |
Correlation between pneumonia severity index and mortality within 30 days after the diagnosis of community-acquired pneumonia in elderly subjects
O. Ochoa-Gondar, A. Vila-Corcoles, X. Ansa, N. Saun, J. Daniel (Tarragona, Spain)
| |
Incidence of pneumococcal pneumonia in Catalonian elderly people living in the community
O. Ochoa-Gondar, A. Vila-Corcoles, A. Vilanova, F. Bertomeu, J. M. Santamaria, EVAN-50 Study Group (Tarragona, Spain)
| |
Characterization of the duration from onset of asthma symptoms to asthma diagnosis
Y. J. Juhn, H. Kita, L. A. Lee, S. M. Bagnieski, A. L. Weaver, R. M. Jacobson, W. E. Molis (Rochester, United States Of America)
| |
Prevalence of COPD in daily medical care: preoperative inspection/clinical survey/primary care clinics
T. Tsuda, H. Yano, H. Ohmori, K. Takeharu, K. Watanabe, H. Aizawa, Fukuoka COPD Research Group (Kurume, Japan)
| |
COPD prevalence data derived from a health screening clinic – less bias than expected
B. Lamprecht, L. Schirnhofer, M. Studnicka (Salzburg, Austria)
| |
Use of lung function laboratory by general practitioners
K. Walraven, N. Broers, E. F. M. Wouters, G. Wesseling (Maastricht, Netherlands)
| |
Pulmonary function of inhaled human insulin (Exubera®) in patients with type 2 diabetes: results from a 2-year study using standardized methodology
P. Lange, S. Klioze, H. Foyt, M. Ogawa, L. St Aubin, W. Duggan, R. J. Riese, J. G. Teeter (Hvidovre, Denmark; Groton, Ann Arbor, United States Of America)
| |
Asthma insight and reality in Thailand
W. Boonsawat, U. Zaeoui, S. Lerdsinudom, C. Samosorn (Khonkaen, Khon Kaen, Thailand)
| |
Psychosomatic evaluation of outpatients treated in an asthma education program (PAPA)
J. X. Paiva, R. S. Vasconcelos, M. N. C. Silva, A. L. G. Fernandes, M. D. R. S. R. Costa (Sao Luis, Sao Paulo, Brazil)
| |